Metraipolis › archive › dc_346972143597
In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33553164
- DOI
- 10.3389/fcell.2020.624477
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-10T01:26:40.988Z
- SHA-256 of the archived text
790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed- Stable URL of this page
https://metraipolis.com/documento/dc_346972143597
How to cite
In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164 — Europe PMC (en), https://europepmc.org/article/MED/33553164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_346972143597 (Metraipolis archive dc_346972143597, sha256 790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed)
BibTeX
@misc{dc346972143597,
title = {In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System — Europe PMC PMID:33553164},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33553164},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_346972143597; sha256 790f6b8dd61bc1ef968346a79c1e5ed1fe0f4cc256baa371842bc77ff85a5bed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33553164. Agents can read the archived copy with the MCP tool read_document.